The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sullivan Christopher Ryan since 2020.
This trader's CIK number is 1810417.
At the time of last reporting, Sullivan Christopher Ryan was the Chief Financial Officer of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX).
Also see all insider trading activities at Avalo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AVTX | 0 | $0 | 0 | $0 | 24,200 | $0 |
| 2023 | AVTX | 511 | $1,747 | 0 | $0 | 0 | $0 |
| 2021 | AVTX | 955 | $1,499 | 0 | $0 | 0 | $0 |
| 2020 | AVTX | 8,049 | $18,335 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-28 | AVTX | Option Ex | 24,200 | .00 | 0 |
| 2023-06-09 | AVTX | Buy | 511 | 3.42 | 1,747 |
| 2021-12-10 | AVTX | Buy | 955 | 1.57 | 1,499 |
| 2020-12-10 | CERC | Buy | 5,095 | 2.28 | 11,606 |
| 2020-06-10 | CERC | Buy | 2,954 | 2.28 | 6,729 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sullivan Christopher Ryan (Chief Financial Officer of Avalo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.